The largest database of trusted experimental protocols

Elisa kit against human bdnf

Manufactured by Boster Bio
Sourced in United States

The ELISA kit against human BDNF is a laboratory tool designed to quantify the levels of brain-derived neurotrophic factor (BDNF) in human samples. It employs the enzyme-linked immunosorbent assay (ELISA) technique to detect and measure the concentration of this specific protein.

Automatically generated - may contain errors

2 protocols using elisa kit against human bdnf

1

BDNF Quantification by ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The amount of immobilized and released BDNF was quantified by an enzyme-linked immunosorbent assay (ELISA) kit against human BDNF (Boster Biological Technology Co., Ltd., Pleasanton, United States). The BDNF-ELISA kit was used in accordance to the manufacturer’s recommendations. A brief summary of the procedure follows. The 96-well plate delivered had been pre-coated with a monoclonal antibody for BDNF. Standards and samples were diluted in sample dilution buffer and added to the wells for 90 min. After the incubation, the plate content was discarded and a working solution of a biotinylated anti-human BDNF antibody was added for 60 min. After three washing steps with PBS, an incubation with a working solution containing an avidin-biotin-peroxidase complex followed (30 min). Further washing steps with PBS to remove the unbound complex were performed. For colorimetric detection 3,3′,5,5′-tetramethylbenzidine was added. The color development was stopped with 2 M sulfuric acid. All incubation steps were performed at 37°C. Absorbance was recorded at 450 nm on an EON spectrophotometer (Biotek, Winooski, United States).
+ Open protocol
+ Expand
2

BDNF Quantification via ELISA Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the quantification of the amount of immobilized and released BDNF an enzyme-linked immunosorbent assay (ELISA) kit against human BDNF (Boster Biological Technology Co., Ltd., Pleasanton, USA) was applied. The BDNF-ELISA kit was used in accordance to the manufacturer´s recommendations. In brief, a monoclonal antibody for BDNF had been precoated onto the 96-well plate. Standards and samples were diluted in sample dilution buffer and were added to the wells. After an incubation period of 90 min, the plate content was discarded and a working solution of a biotinylated anti-human BDNF antibody was added for 60 min. This was followed by three washing steps with PBS and by the incubation with a working solution containing an avidin-biotin-peroxidase complex. Then, the unbound conjugates were washed off with PBS. Finally, the detection was performed with 3,3´,5,5´-tetramethylbenzidine and stopped with 2 M sulphuric acid. All incubation steps were performed at 37°C. Absorbance was read at 450 nm on an EON spectrophotometer (Biotek, Winooski, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!